# BPC-157: research reference

For research use only. Checked November 1, 2026.

BPC-157 is a synthetic 15-residue peptide investigated in tissue-repair research. Frequently cited tendon studies examine rat-derived cells and explants, not clinical recovery in people. Those experiments report changes in cell movement and growth-factor responsiveness, but they do not establish a universal repair mechanism or validate a supplier's product. The useful starting point is the exact experimental model, measured endpoint and chemical identity.

## Identity
The cited literature describes the pentadecapeptide sequence GEPPPGKPADDAGLV. A catalog name is not an identity test: a reference material still needs an appropriate analytical identity record, composition specification and lot traceability. Do not treat research on the named sequence as proof that an untested vial contains it.

## Mechanism
The 2011 tendon-fibroblast work examined migration, explant outgrowth and signaling associated with cell movement. These are experimentally measurable behaviors; they should not be collapsed into the broader claim that a material repairs every type of tissue.

The 2014 study asked a narrower question about growth-hormone-receptor expression and subsequent responsiveness in rat tendon fibroblasts. Receptor-expression changes in a cell preparation are not equivalent to demonstrating whole-organism growth effects. The two papers investigate related but distinct parts of tendon biology.

## Selected research
### Tendon-cell movement and explant outgrowth
Model: Rat tendon explants and cultured fibroblasts

Chang and colleagues reported greater tendon-cell outgrowth and migration, with changes in cytoskeletal/signaling read-outs.

Limitation: An experimental cell/explant result does not measure clinical injury recovery or independently establish human efficacy.

### Growth-factor responsiveness
Model: Fibroblasts isolated from rat Achilles tendon

A later experiment reported increased growth-hormone-receptor expression and a stronger proliferation response to growth hormone in the prepared cells.

Limitation: The receptor and proliferation findings are model-specific; a complete causal explanation and generalizability require additional experiments.

## Open questions
- Which proposed pathways are necessary rather than merely associated with the observed endpoints? A useful follow-up would interrupt the proposed pathway and test whether the result remains.
- How reproducible are the findings across laboratories, cell donors, injury models and independently characterized materials? Multiple papers from related investigators are not the same as broad independent replication.
- These selected studies do not answer human clinical effectiveness, long-term outcomes, or the equivalence of different commercial formulations. They are landmark examples, not a systematic inventory of all research.

## Storage and handling
No universal storage temperature or shelf life is established by the selected tendon papers. Use the documentation for the exact material, form, container and lot.

Record analytical identity, assay basis and any counterion or formulation details separately from the product name. A general stability statement must not be extended to every solution or blend.

## Sources
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration (2011). https://pubmed.ncbi.nlm.nih.gov/21030672/
- Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts (2014). https://pubmed.ncbi.nlm.nih.gov/25415472/

For research use only. Primary bibliographic records and abstracts checked November 1, 2026. This is an editorial research reference, not a systematic review or completed independent scientific review. No human-use guidance.